24314-25-8 Usage
Heterocyclic ring
A six-membered ring containing one oxygen and one nitrogen atom.
3-Bromophenyl group
A phenyl group (a six-membered ring with alternating single and double carbon-carbon bonds) substituted with a bromine atom at the 3-position (the position adjacent to the heterocycle).
Trimethyl substitution
Three methyl groups (CH3) are attached to the 4and 6-positions of the 1,3-oxazine ring.
Dihydro
The compound has two hydrogen atoms added to the 5,6-positions of the 1,3-oxazine ring, making it a dihydro derivative.
4H-1,3-oxazine
The compound belongs to the 1,3-oxazine family and has a four-membered nitrogen-containing ring fused to the six-membered heterocyclic ring.
Potential applications
The compound may have uses in organic chemistry and pharmaceutical research, possibly as a building block for synthesizing complex organic molecules or as a new drug candidate.
Unique properties
The compound may possess unique chemical and biological properties that distinguish it from other related compounds.
Further research
Additional investigation is needed to fully understand the capabilities and applications of 2-(3-bromophenyl)-4,4,6-trimethyl-5,6-dihydro-4H-1,3-oxazine.
Check Digit Verification of cas no
The CAS Registry Mumber 24314-25-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,3,1 and 4 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 24314-25:
(7*2)+(6*4)+(5*3)+(4*1)+(3*4)+(2*2)+(1*5)=78
78 % 10 = 8
So 24314-25-8 is a valid CAS Registry Number.
24314-25-8Relevant articles and documents
4-Benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists
Wijtmans, Maikel,Celanire, Sylvain,Snip, Erwin,Gillard, Michel R.,Gelens, Edith,Collart, Philippe P.,Venhuis, Bastiaan J.,Christophe, Bernard,Hulscher, Saskia,Van Der Goot, Henk,Lebon, Florence,Timmerman, Henk,Bakker, Remko A.,Lallemand, Bénédicte I. L. F.,Leurs, Rob,Talaga, Patrice E.,De Esch, Iwan J. P.
supporting information; experimental part, p. 2944 - 2953 (2009/04/11)
Research on the therapeutic applications of the histamine H3 receptor (H3R) has traditionally focused on antagonists/inverse agonists. In contrast, H3R agonists have received less attention despite their potential use in s
